Aehr Test Systems (NASDAQ:AEHR) Reaches New 52-Week High – What’s Next?

Aehr Test Systems (NASDAQ:AEHR) reached a new 52-week high during trading on Monday . The stock traded as high as $50.80 and last traded at $51.2880, with a volume of 2841483 shares trading hands. The stock had previously closed at $44.32.

Analysts Set New Price Targets

AEHR has been the subject of a number of analyst reports. Weiss Ratings restated a “sell (d)” rating on shares of Aehr Test Systems in a research report on Wednesday, January 21st. William Blair upgraded shares of Aehr Test Systems from a “market perform” rating to an “outperform” rating in a research note on Monday, March 2nd. Lake Street Capital assumed coverage on Aehr Test Systems in a report on Wednesday, December 17th. They set a “buy” rating on the stock. Craig Hallum restated a “hold” rating on shares of Aehr Test Systems in a research report on Friday, January 9th. Finally, Zacks Research upgraded Aehr Test Systems from a “strong sell” rating to a “hold” rating in a report on Monday, December 8th. Two equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $21.00.

Aehr Test Systems Stock Up 16.8%

The stock has a market cap of $1.59 billion, a P/E ratio of -172.73 and a beta of 2.28. The company’s 50 day moving average price is $34.26 and its two-hundred day moving average price is $28.39.

Aehr Test Systems (NASDAQ:AEHR) last posted its quarterly earnings results on Thursday, January 8th. The semiconductor company reported ($0.04) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.04. Aehr Test Systems had a negative return on equity of 4.57% and a negative net margin of 16.63%.The business had revenue of $9.88 million for the quarter, compared to the consensus estimate of $11.45 million. As a group, equities research analysts forecast that Aehr Test Systems will post 0.1 earnings per share for the current year.

Insiders Place Their Bets

In other Aehr Test Systems news, Director Laura Oliphant sold 4,546 shares of the stock in a transaction on Thursday, January 22nd. The stock was sold at an average price of $31.40, for a total transaction of $142,744.40. Following the sale, the director owned 18,432 shares of the company’s stock, valued at approximately $578,764.80. This trade represents a 19.78% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Rhea J. Posedel sold 13,998 shares of the firm’s stock in a transaction dated Friday, February 13th. The shares were sold at an average price of $30.02, for a total value of $420,219.96. Following the sale, the director directly owned 456,979 shares in the company, valued at approximately $13,718,509.58. The trade was a 2.97% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 6.80% of the stock is owned by corporate insiders.

Institutional Trading of Aehr Test Systems

Several hedge funds and other institutional investors have recently made changes to their positions in AEHR. Royal Bank of Canada lifted its holdings in shares of Aehr Test Systems by 262.7% during the 1st quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company’s stock valued at $365,000 after purchasing an additional 36,364 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Aehr Test Systems by 8.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company’s stock worth $126,000 after buying an additional 1,344 shares during the last quarter. JPMorgan Chase & Co. increased its position in Aehr Test Systems by 7.9% during the 2nd quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company’s stock valued at $201,000 after buying an additional 1,145 shares in the last quarter. Legal & General Group Plc increased its position in Aehr Test Systems by 110.8% during the 2nd quarter. Legal & General Group Plc now owns 6,882 shares of the semiconductor company’s stock valued at $89,000 after buying an additional 3,617 shares in the last quarter. Finally, Rhumbline Advisers raised its stake in Aehr Test Systems by 3.1% in the second quarter. Rhumbline Advisers now owns 41,466 shares of the semiconductor company’s stock valued at $536,000 after buying an additional 1,254 shares during the last quarter. Hedge funds and other institutional investors own 69.69% of the company’s stock.

Aehr Test Systems Company Profile

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.